This protocol addresses solid papillary carcinoma of the breast with evidence of invasion presenting in the setting of inflammatory breast cancer or locally advanced breast cancer — a clinical situation that follows a structured pre-operative treatment pathway.
The patient has solid papillary carcinoma of the breast with evidence of invasion in the context of inflammatory breast cancer and/or locally advanced breast cancer. The majority of inflammatory cancers are managed with a pre-operative systemic approach, followed by definitive surgery and radiotherapy.
The initial approach involves neo-adjuvant (pre-operative) chemotherapy. The primary goal is reduction in breast tumour size, with response reassessed at 3–4 cycles. Multiple chemotherapy regimen options are available — the complete selection, sequencing, and full regimen details are available in the structured protocol.
The majority of inflammatory cancers will be treated with neo-adjuvant chemotherapy, definitive mastectomy followed by postoperative radiotherapy.
FEC x 6 – reassess at 3-4 cycles.
View source ↗